logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Lung cancer: sarcopenia common, predicts poorer survival in meta-analysis

Prevalence was 43% in patients with NSCLC, 52% in those with SCLC.